Wayland Provides Update on German Tender Process

TORONTO, April 17, 2019 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) would like to address recent reports in the media about the selection process in Germany for domestic medical cannabis cultivation. Earlier today, the German Federal Institute for Drugs and Medical Devices (“BfArM”) announced that 9 of the 13 […]

READ MORE: https://www.newcannabisventures.com/wayland-provides-update-on-german-tender-process/